Wegovy

Stories 21 - 24 | << Prev 

It's the 'Most Efficacious Drug Ever Approved for Obesity'

FDA approves Zepbound, new version of diabetes drug Mounjaro

(Newser) - A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, US regulators announced Wednesday. NBC News reports the FDA approved Eli Lilly's Zepbound, or tirzepatide, a drug that helped dieters lose 22.5% of their body weight (or 52 pounds) in its phase...

Drugs Like Ozempic May Help People Stop Drinking

Researchers looking into anecdotal reports of curbed drinking, other addictive habits

(Newser) - The popular diabetes and obesity drug Ozempic appears to have an intriguing and welcome side effect in some people: It helps them curb drinking, reports NPR . In fact, researchers are looking into the possibility that this class of drug (GLP-1) might also reduce cravings for cigarettes and opioids as well—...

Popular Weight-Loss Drugs May Carry an Unexpected Risk

Anesthesiologists say patients on them may not have empty stomachs needed for unrelated surgeries

(Newser) - Patients who take blockbuster drugs like Wegovy or Ozempic for weight loss may face life-threatening complications if they need surgery or other procedures that require empty stomachs for anesthesia, per the AP . Anesthesiologists in the US and Canada say they've seen growing numbers of patients on the weight-loss drugs...

Weight-Loss Drug May Cut Heart Risks, Too
Study May Change Coverage
for Weight-Loss Drugs
new study

Study May Change Coverage for Weight-Loss Drugs

Maker of Wegovy cites heart benefits, which could pressure insurers to start covering

(Newser) - A new study suggests the popular weight-loss drug Wegovy might cut the risk of heart disease as well. If the study is confirmed—and it hasn't yet been peer-reviewed—the results could pressure insurers to start covering the pricey drug, reports the New York Times . Maker Novo Nordisk charges...

Stories 21 - 24 | << Prev 
Most Read on Newser